Skip to main content
SpringerLink
Log in

Analysis of CerbB2 protein content of human glioma cells and tumor tissue

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

This study was designed to determine whether or not overexpression of the cerbB2 protein plays a role in the etiology of human gliomas. The cerbB2 gene codes for a 185 kDa cell membrane glycoprotein (gpl85cerbB2), which is similar to the receptor for epidermal growth factor. In initial studies, four human glioma cell lines (A-172, U118MG, U138MG and SW608) were used to develop techniques for detecting and quantifying gpl85cerbB2, using immunofluorescence microscopy, immunoblot analysis and flow cytometry. A-172 cells were found to have the highest content of gpl85cerbB2. More detailed studies utilizing A-172 cells indicated that cellular gpl85cerbB2 content changed little in response to conditions affecting cellular proliferative status, including serum deprivation, growth in low glucose medium and treatment with dimethyl sulfoxide. Ten human glioma specimens were then analyzed for cellular gpl85cerbB2 fluorescence and DNA content, using A-172 cells as a biological standard. Results indicated that gpl85cerbB2 was expressed at levels comparable to that of A-172 cells in many specimens, and at a very high level in one specimen. These data reiterate the problem of themolecular heterogeneity of human gliomas and indicate that gpl85cerbB2 may have a role in at least asubset of malignant glial tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aasland R, Lillehaug JR, Male R, Josendal O, Varhaug JE, Kleppe K: Expression of oncogenes in thyroid tumours: Coexpression of c-erbB2/neu and c-erbB. Br J Cancer 57: 358–363, 1988

    Google Scholar 

  2. Bishop JM: Science 235: 305–311, 1987

    Google Scholar 

  3. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 117–182, 1987

    Google Scholar 

  4. Yanamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K: Similarity of protein encoded by the human c-erbB2 gene to epidermal growth factor receptor. Nature 319: 230–234, 1986

    Google Scholar 

  5. Engelhard HH, Butler AB, Bauer KD: Quantification of the c-myc oncoprotein in human glioblastoma cells and tumor tissue. J Neurosurg 71: 224–232, 1989

    Google Scholar 

  6. Fujimoto M, Sheridan P, Sharp D, Weaker F, Kagan-Hallet K, Story J: Proto-oncogene analyses in brain tumors. J Neurosurg 70: 910–915, 1989

    Google Scholar 

  7. U HS, Kelley P, Hatton JD, Shew JY: Proto-oncogene abnormalities and their relationship to tumorigenicity in some human glioblastoma. J Neurosurg 71: 83–90, 1989

    Google Scholar 

  8. Whittle IR: Oncogenes and neuro-oncology. Brit J Neurosurg 3: 3–12, 1989

    Google Scholar 

  9. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T: The product of the human c-erbB2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232: 1644–1646, 1986

    Google Scholar 

  10. Bargmann CI, Hung MC, Weinberg RA:Theneu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319: 226–230, 1986

    Google Scholar 

  11. Coussens L, Yang-Freng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg P, Libermann TA, Schlessinger J, Francke U, Levinson A, Ullrich A: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location withneu oncogene. Science 230: 1132–1139, 1985

    Google Scholar 

  12. Schlechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI, Weinberg RA, Yang-Feng TL, Francke U, Ullrich A, Coussens L: Theneu oncogene: AnerbB-related gene encoding a 185,000-Mr tumour antigen. Nature 312: 513–516, 1984

    Google Scholar 

  13. Semba K, Kamata N, Toyoshima K, Tamamoto T: A v-erbrelated protooncogene, c-erbB-2, is distinct from the c-erb-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci 82: 6497–6501, 1985

    Google Scholar 

  14. Fukushige S, Matsubara K, Yoshida M, Sasaki M, Suzuki T, Semba K, Toyoshima K, Yamamoto T: Localization of a novel v-erbB-related gene, c-erbB2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol Cell Biol 6: 955–958, 1986

    Google Scholar 

  15. VandeVijver M, Berselaar R, Devilee P: Amplification of thenew-gene encoded protein (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accomplished by amplification of the linked c-erbA oncogene. Mol Cell Biol 7: 2019–2023, 1987

    Google Scholar 

  16. Bargmann CI: The neu/c-erbB-2 oncogene. In: Reddy EP, Skalka AM, Curran T (eds) The Oncogene Handbook, New York: Elsevier Science Publishers, pp 107–119, 1988

    Google Scholar 

  17. Padhy LC, Shih C, Cowing D, Finkelstein R, Weinberg RA: Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastoma. Cell 28: 865–871, 1982

    Google Scholar 

  18. Shih C, Padhy LC, Murray M, Weinberg RA: Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261–263, 1981

    Google Scholar 

  19. DiFiore PPD, Segatto O, Taylor WG, Aaronson SA, Pierce JH: EGF receptor anderbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science 248: 79–83, 1990

    Google Scholar 

  20. Ulrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203–212, 1990

    Google Scholar 

  21. Segatto O, Lonardo F, Wexler D, Fazioli F, Pierce JH, Bottaro DP, White MF, Di Fiore PP: The juxtamembrane regions of the epidermal growth factor receptor and gpl85erbB-2 determine the specificity of signal transduction. Proc Natl Acad Sci 82: 3191–3202, 1991

    Google Scholar 

  22. Hynes NE, Gerber HA, Saurer S, Groner B: Overexpression of the c-erbB-2 protein in human breast tumor cell lines. J Cell Biochem 39: 167–173, 1989

    Google Scholar 

  23. Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR: IncreasederbB-2 gene copies and expression in multiple stages of breast cancer. Cancer Res 50: 6701–6707, 1990

    Google Scholar 

  24. McCann A, Dervan PA, Johnston PA, Gullick WJ, Carney DN: C-erbB-2 oncoprotein expression in primary human tumors. Cancer 65: 88–92, 1990

    Google Scholar 

  25. Mori S, Akiyama T, Morishita Y, Shimizu S, Sakai K, Sudoh K, Toyoshima K, Yamamoto T: Light and electron microscopical demonstration of c-erbB-2 gene product-like immunoreactivity in human malignant tumors. Virchows Arch B 54: 8–15, 1987

    Google Scholar 

  26. Paterson MC, Dietrich KD, Danyluk J, Paterson AHG, Less AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA, Slamon DJ, Fourney RM: Correlation between cerbB-2 amplification and risk of recurrent disease in nodenegative breast cancer. Cancer Res 51: 556–557, 1991

    Google Scholar 

  27. Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazdar A, Greene GI, Williams WV, Cohen JA, Kern JA: Expression of theneu gene-encoded protein (pl85neu) in human non-small cell carcinomas of the lung. Cancer Res 50: 421–425, 1990

    Google Scholar 

  28. Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield M, Groner B, Hynes N: Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48: 1238–1243, 1988

    Google Scholar 

  29. Guerin M, Gabillot M, Mathier MC, Travagli JP, Spielman M, Andrieu N, Riou G: Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: Prognostic significance. Int J Cancer 43: 201–208, 1989

    Google Scholar 

  30. Parkes HC, Lillycrop K, Howell A, Craig RK: C-erbB-2 mRNA expression in human breast tumours: Comparison with c-erbB-2 amplification and correlation with prognosis. Br J Cancer 61: 39–45, 1990

    Google Scholar 

  31. Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endou Y, Tanaka M, Sasaki T: Evaluation of immunoreactivity forerbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res 51: 1034–1038, 1991

    Google Scholar 

  32. Schmidek HH: The molecular genetics of nervous system tumors. J Neurosurg 67: 1–16, 1987

    Google Scholar 

  33. Maguire HC, Greene MI: Theneu (c-erbB-2) oncogene. Semin Oncol 16: 148–155, 1989

    Google Scholar 

  34. LaRocca RV, Rosenblum M, Westermark B, Israel MA: Patterns of proto-oncogene expression in human glioma cell lines. J Neuroscience Res 24: 97–106, 1989

    Google Scholar 

  35. Bernstein JJ, Anagnostopoulos AV, Hattwick EA, Laws ER: Human-specific c-neu proto-oncogene protein overexpression in human malignant astrocytomas before and after xenografting. J Neurosurg 78: 240–251, 1993

    Google Scholar 

  36. Gullick W, Berger MS, Bennett PLP, Rothbard JB, Waterfield MD: Expression of the c-erbB-2 protein in normal and transformed cells. Int J Cancer 40: 246–254, 1987

    Google Scholar 

  37. Alper O, Yamaguchi K, Hitomi J, Honda S, Matsushima T, Abe K: The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3. Cell Growth Diff 1: 591–599, 1990

    Google Scholar 

  38. Engelhard HH: A quantitative analysis of modulations occuring in cellular c-myc protein content, %S phase and growth balance under growth-inhibitory conditions. Mol Cell Biol 39: 607–620, 1993

    Google Scholar 

  39. Drebin JA, Stern DF, Link VC, Weinberg RA, Greene MI: Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene. Nature 312: 545–548, 1984

    Google Scholar 

  40. McKenzie SJ, Marks PJ, Lam T, Morgan J, Panicali DL, Trimpe KL, Carney WP: Generation and characterization of monoclonal antibodies specific for the humanneu oncogene product, p185. Oncogene 4: 543–548, 1989

    Google Scholar 

  41. Akiyama T, Saito T, Ogawara H, Toyoshima K, Yamamoto T: Tumor promoter and epidermal growth factor stimulate phosphorylation of the c-erbB-2 gene product in MKN-7 human adenocarcinoma cells. Mol Cell Biol 8: 1019–1026, 1988

    Google Scholar 

  42. Thor AD, Schwartz LH, Koerner FC, Edgerton SM, Skates SJ, Yin S, McKenzie SJ, Panicali DL, Marks PJ, Fingert HJ, Wood WC: Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up. Cancer Res 49: 7147–7152, 1989

    Google Scholar 

  43. Marth C, Muller-Holzer E, Greiter E, Cronauer MV, Zeimet AG, Doppler W, Eible B, Hynes NE, Daxenbichler G: Interferon reduces expression of the proto-oncogene cerbB-2 in human ovarian carcinoma cells. Cancer Res 50: 7037–7041, 1990

    Google Scholar 

  44. Tsujino T, Yoshida K, Nakayama H, Ito H, Shimosato T, Tahara E: Alterations of oncogenes in metastatic tumors of human gastric carcinomas. British Cancer 62: 226–230, 1990

    Google Scholar 

  45. Makar PA, Desmedt EJ, De Potter CR, Vanderheyden JS, Schatteman EA:Neu (c-erbB2) oncogene in breast cancer and its possible association with the risk of distant metastases. Acta Oncologica 29: 931–934, 1990

    Google Scholar 

  46. Schechter AL, Hung MC, Vaidyanathan L, Weinberg RA, Yang-Feng TL, Ullrich A, Coussens L: Theneu gene: AnerbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229: 976–978, 1985

    Google Scholar 

  47. Cavenee WK: Accumulation of genetic defects during astrocytoma progression. Cancer Supplement 70: 1788–1793, 1992

    Google Scholar 

  48. Yarden Y: Agonistic antibodies stimulate the kinase encoded by theneu protooncogene in living cells but the oncogenic mutant is constituitively active. Proc Natl Acad Sci 87: 2569–2573, 1990

    Google Scholar 

  49. Stern DF, Hefferman PA, Weinberg RA: Product of theneu proto-oncogene, is a receptor-like protein associated with tyrosine kinase activity. Mol Cell Biol 6: 1729–1740, 1986

    Google Scholar 

  50. Weiner DB, Kokai Y, Wada T, Cohen JA, Williams WV, Greene MI: Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein. Oncogene 4: 1175–1183, 1989

    Google Scholar 

  51. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield M, Ullrich A, Schlessinger J: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313: 144–147, 1985

    Google Scholar 

  52. Maiden LT, Novak U, Kaye AH, Burgess AW: Selective amplification of the cytoplasmic domain of epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res 48: 2711–2714, 1988

    Google Scholar 

  53. King CR, DiFiore PP, Pierce JH, Segatto O, Kraus MH, Aaronson SA: Oncogenic potential of theerbB-2 gene: frequent overexpression in human mammary adenocarcinomas and induction of transformationin vitro: Growth regulation of cancer, New York: Alan R. Liss, Inc., pp 189–199, 1988

    Google Scholar 

  54. Drebin JA, Link VC, Weinberg RA, Greene MI: Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. Proc Natl Acad Sci 83: 9129–9133, 1986

    Google Scholar 

  55. Langton BC, Crenshaw MC, Chao LA, Stuart SG, Akita RW, Jackson JE: An antigen immunologically related to the external domain of gpl85 is shed from nude mouse tumors overexpressing the c-erbB-2 HER/2/neu) oncogene. Cancer Res 51: 2593–2598, 1991

    Google Scholar 

  56. Pupa SM, Menard S, Andreola S, Mcolnaghi MI: Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients. Cancer Res 53: 5864–5866, 1993

    Google Scholar 

  57. Saga T, Endo K, Akiyama T, Koizumi M, Watanabe Y, Nakai T, Hosono M, Yamamoto T, Toyoshima K, Konishi J: Scintigraphic detection of overexpressed c-erbB-2 proto-oncogene products by a class-switched murine anti-c-erbB-2 protein monoclonal antibody. Cancer Res 51: 990–994, 1991

    Google Scholar 

  58. Drebin JA, Link VC, Stern DF, Weinberg RA, Greene MI: Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Cell 41: 695–706, 1985

    Google Scholar 

  59. Kraus MH, Popescu NC, Amsbaugh SC, King CR: Overexpression of the EGF receptor-related proto-oncogeneerbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6: 605–610, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neurosurgery, Department of Surgery, Northwestern University Medical School, 60611, Chicago, Illinois, USA

    Herbert H. Engelhard

  2. Brain Tumor Research Laboratory, University of Louisville, 40292, Louisville, Kentucky, USA

    Herbert H. Engelhard, Mark Wolters & Peggy S. Criswell

Authors
  1. Herbert H. Engelhard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark Wolters
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peggy S. Criswell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Engelhard, H.H., Wolters, M. & Criswell, P.S. Analysis of CerbB2 protein content of human glioma cells and tumor tissue. J Neuro-Oncol 23, 31–40 (1995). https://doi.org/10.1007/BF01058457

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01058457

Key words

Search

Navigation